These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 12660945

  • 1. Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients.
    Hofmann WP, Sarrazin C, Kronenberger B, Schönberger B, Bruch K, Zeuzem S.
    J Infect Dis; 2003 Mar 15; 187(6):982-7. PubMed ID: 12660945
    [Abstract] [Full Text] [Related]

  • 2. Mutations in the putative HCV-E2 CD81 binding regions and correlation with cell surface CD81 expression.
    Kronenberger B, Sarrazin C, Hofmann WP, von Wagner M, Herrmann E, Welsch C, Elez R, Rüster B, Piiper A, Zeuzem S.
    J Viral Hepat; 2004 Jul 15; 11(4):310-8. PubMed ID: 15230853
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis C virus-related resistance mechanisms to interferon alpha-based antiviral therapy.
    Hofmann WP, Zeuzem S, Sarrazin C.
    J Clin Virol; 2005 Feb 15; 32(2):86-91. PubMed ID: 15653410
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interferon alfa down-regulates CD81 in patients with chronic hepatitis C.
    Kronenberger B, Rüster B, Elez R, Weber S, Piiper A, Lee JH, Roth WK, Zeuzem S.
    Hepatology; 2001 Jun 15; 33(6):1518-26. PubMed ID: 11391542
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.
    Nattermann J, Zimmermann H, Iwan A, von Lilienfeld-Toal M, Leifeld L, Nischalke HD, Langhans B, Sauerbruch T, Spengler U.
    Hepatology; 2006 Oct 15; 44(4):945-54. PubMed ID: 17006905
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding.
    McCaffrey K, Boo I, Poumbourios P, Drummer HE.
    J Virol; 2007 Sep 15; 81(17):9584-90. PubMed ID: 17581991
    [Abstract] [Full Text] [Related]

  • 13. Using evolutionary tools to refine the new hypervariable region 3 within the envelope 2 protein of hepatitis C virus.
    Torres-Puente M, Cuevas JM, Jiménez-Hernández N, Bracho MA, García-Robles I, Wrobel B, Carnicer F, del Olmo J, Ortega E, Moya A, González-Candelas F.
    Infect Genet Evol; 2008 Jan 15; 8(1):74-82. PubMed ID: 18063425
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CD81 binding regions of hepatitis C virus remain conserved after liver transplantation.
    Lyra AC, Fan X, Di Bisceglie AM.
    Braz J Infect Dis; 2004 Apr 15; 8(2):126-32. PubMed ID: 15361990
    [Abstract] [Full Text] [Related]

  • 17. Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in Japanese patients infected with HCV genotypes 2a and 2b.
    Saito T, Ito T, Ishiko H, Yonaha M, Morikawa K, Miyokawa A, Mitamura K.
    Am J Gastroenterol; 2003 Jun 15; 98(6):1377-83. PubMed ID: 12818284
    [Abstract] [Full Text] [Related]

  • 18. Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C.
    Mihm U, Grigorian N, Welsch C, Herrmann E, Kronenberger B, Teuber G, von Wagner M, Hofmann WP, Albrecht M, Lengauer T, Zeuzem S, Sarrazin C.
    Antivir Ther; 2006 Jun 15; 11(4):507-19. PubMed ID: 16856625
    [Abstract] [Full Text] [Related]

  • 19. Sequence diversity of hepatitis C virus 6a within the extended interferon sensitivity-determining region correlates with interferon-alpha/ribavirin treatment outcomes.
    Zhou DX, Chan PK, Zhang T, Tully DC, Tam JS.
    Virus Res; 2010 Oct 15; 153(1):44-9. PubMed ID: 20624431
    [Abstract] [Full Text] [Related]

  • 20. A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.
    Drummer HE, Boo I, Maerz AL, Poumbourios P.
    J Virol; 2006 Aug 15; 80(16):7844-53. PubMed ID: 16873241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.